PRO-DEX, INC. Increase (Decrease) in Accounts and Other Receivables
PRO-DEX, INC. (PDEX) reported Increase (Decrease) in Accounts and Other Receivables of $2.23 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-04-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2026-04-30
- PRO-DEX, INC. increase (decrease) in accounts and other receivables for the quarter ending 2026-03-31 was $764.00K.
- PRO-DEX, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-12-31 was -$334.00K, a 106.63% decline year-over-year.
- PRO-DEX, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-09-30 was $1.80M.
- PRO-DEX, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-03-31 was -$2.63M.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month |
|---|---|---|---|
| 2026-03-31 | $764.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-30 | $430.00K derived: sum of 2 quarters · filed 2026-04-30 | $2.23M 10-Q · filed 2026-04-30 |
| 2025-12-31 | -$334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-29 | $1.47M 10-Q · filed 2026-01-29 | |
| 2025-09-30 | $1.80M 10-Q · filed 2025-10-30 | ||
| 2025-03-31 | -$2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-30 | $2.40M derived: sum of 2 quarters · filed 2026-04-30 | $1.97M 10-Q · filed 2026-04-30 |
| 2024-12-31 | $5.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-29 | $4.61M 10-Q · filed 2026-01-29 | |
| 2024-09-30 | -$428.00K 10-Q · filed 2025-10-30 | ||
| 2023-09-30 | $1.08M 10-Q · filed 2023-11-02 | ||
| 2023-03-31 | -$4.82M 10-Q · filed 2023-05-04 | ||
| 2022-09-30 | -$4.34M 10-Q · filed 2023-11-02 | ||
| 2022-03-31 | -$174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-04 | -$2.25M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | -$2.08M 10-Q · filed 2022-02-03 | ||
| 2021-03-31 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-05 | $6.77M 10-Q · filed 2022-05-05 | |
| 2020-12-31 | -$535.00K 10-Q · filed 2022-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |